Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 519.47% and ...

From transformative weight loss treatment to a potential blockbuster for Alzheimer's, Dave Ricks of Eli Lilly is having a ...

In light of the recent options history for Eli Lilly, it's now appropriate to focus on the company itself. We aim to explore its current performance. Where Is Eli Lilly Standing Right Now?

Eli Lilly and Company reported third quarter results and ... And we see a similar picture for adjusted earnings per share. Instead of a previous guidance of $16.10 to $16.60 for non-GAAP earnings ...

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca® (pirtobrutinib), a non-covalent (reversible) Bruton's tyrosine kinase (BTK) inhibitor, will be presented at ...

Conditions are getting a bit more challenging for the drugmaker.

But earnings in the new range would still wind up being more than twice what the company registered for 2023. Shares of Indianapolis-based Eli Lilly and Co. were down 6%, or $57.02, to $846.56 in ...

Eli Lilly executives insisted that underlying demand for the medicines remained strong and that the company has enough supply available. During an earnings call Wednesday, Eli Lilly instead blamed ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other pharma stocks. Healthcare takes the concept of 'defensive' further than almost any ...

SALISBURY — Rowan-Cabarrus Community College and its students recently benefited from involvement with Eli Lilly and Company and its annual Global Day of Service. Student participation is key to ...

Eli Lilly executives insisted that underlying demand for the medicines remained strong and that the company has enough supply available. The reason for the disappointing sales, according to the ...